Abstract:Background The development of platelet concentrated biomaterials has gained increasing awareness for regenerative medicine. With different protocol, derivatives such as advanced platelet-rich fibrin (A-PRF), injected platelet-rich fibrin, and concentrated growth factor (CGF) have been demonstrated effectively in preclinical and clinical studies. The aim of this study was to compare the level of growth factors releasing from A-PRF and CGF, and their clinical efficacy in the regenerative management of intrabony defects (IBDs). Methods Thirty-two blood samples were collected from eight healthy donors and assessed for platelet-derived growth factor-alpha beta, vascular endothelial growth factor, bone morphogenetic protein-2, and transforming growth factor-beta 1 release at indicated times. In addition, the clinical records of 45 patients (15 per group) who had undergone guided tissue regeneration (GTR) with or without A-PRF/CGF were retrieved. The probing depth (PD) and clinical attachment level (CAL) were recorded preoperatively and 6 months postoperatively. Intrabony component (IC) depth, radiographic bone level (RBL), and bone defect filling were assessed radiographically. Results A-PRF had a looser fibrin network than the CGF but presented larger amounts of growth factors with a more sustained release period. Although there was no difference in PD reduction, CAL gain, RBL height change and defect filling (%) between A-PRF and CGF group, both achieved a more favorable clinical result in IC height reduction and defect filling (%) than the control. Conclusions A-PRF and CGF have the ability to stimulate a continual and steady release of total growth factors over a 14-day period. A-PRF and CGF show a similar effectiveness in periodontal bone regeneration with a potential benefit of improving GTR outcomes in IBD treatment.

Role and mechanism of platelet-derived growth factor in cell proliferation and tissue repair

[Effect of Expression of Platelet-Derived Growth Factor B Gene on Blood Vessel Reconstruction after Tissue Engineering Skin Grafting].

Progress in Human Epidermal Growth Factor Research

Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis

[Roles of Galphaq/11 Mediated- and Platelet-Derived Growth Factor Mediated-Signal Transduction Pathways in Rat Aorta Restenosis].

[The Effects of PL-derived Growth Factor on Osteogenesis and Skeletal Reconstruction].

Roles of the fibroblast growth factor signal transduction system in tissue injury repair

Emerging Roles of PDGF-D in EMT Progression During Tumorigenesis.

Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficiency as adjunctive to the GTR procedure in periodontal intrabony defects

Growth-promoting action and growth factor release by different platelet derivatives

The influence of platelet-derived products on angiogenesis and tissue repair: a concise update

PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics

Cellular Mechanisms of FGF-Stimulated Tissue Repair

Research progress in role and mechanism of neutrophils in tissue repair

Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers

[Research Advances on Biomaterials for the Delivery of Growth Factors to Regulate Wound Repair].

Fibroblast growth factors as tissue repair and regeneration therapeutics

Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review

Expression and effects of epidermal growth factor on human periodontal ligament cells

Current status of drugs targeting PDGF/PDGFR

The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration